stockrowBillionToOne, Inc. (BLLN) vs Veracyte, Inc. (VCYT)
- BillionToOne, Inc. BLLN 111.17 −1.09%
- Veracyte, Inc. VCYT 24.31 +1.29%
BillionToOne, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. BillionToOne, Inc. is the larger, with a market value of $5.3B against $1.9B — 2.7× the size. Veracyte, Inc. trades at the lower P/E: 15.2× against 88.7×. BillionToOne, Inc. grew revenue faster over the last twelve months: 76.5% against 17.5%. Veracyte, Inc. has the higher net margin (21.8% vs 11.2%) and the higher return on invested capital (4.33% vs 0.00%). Across the 19 metrics below, Veracyte, Inc. leads on 15 and BillionToOne, Inc. on 4.
Valuation
Profitability
| Metric | BLLN | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 71.41% | 71.98% | 48.32% |
| Operating margin | 10.23% | 17.08% | (5.68%) |
| Net margin | 11.23% | 21.80% | (4.10%) |
| Free cash flow margin | 7.76% | 27.84% | 0.00% |
| Return on equity | 0.00% | 9.43% | 0.00% |
| Return on assets | 9.02% | 8.63% | (6.05%) |
| Return on invested capital | 0.00% | 4.33% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack